Show Summary Details
Page of

Ovarian hyperstimulation syndromeOvarian hyperstimulation syndromeOvarian hyperstimulation syndrome 

Ovarian hyperstimulation syndromeOvarian hyperstimulation syndromeOvarian hyperstimulation syndrome
Chapter:
Ovarian hyperstimulation syndrome
DOI:
10.1093/med/9780198567301.003.0012
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 19 September 2019

Kamal Ojha

Ovarian hyperstimulation syndrome 246

Ovarian hyperstimulation syndrome (OHSS) is the most serious complication of ovulation induction. With the introduction of gonadotrophin-releasing hormone (GnRH) agonists and the use of higher doses of menotrophins to retrieve a higher number of mature oocytes to maximize ART pregnancy rates, the incidence of severe OHSS has increased. After in vitro fertilization (IVF) and embryo transfer, the overall incidence of OHSS is reported to be 0.6–14%; however, the incidence of severe OHSS is ∼1–2%....

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.